by rss feed | May 14, 2021 | News Feeds
Approval is the most significant advancement in the treatment of chronic kidney disease in more than 20 years. In DAPA-CKD Phase III trial, Farxiga demonstrated unprecedented reduction in the risk of the composite of worsening of renal function, end-stage kidney...
by rss feed | May 14, 2021 | News Feeds
Diaverum, a leading global renal care service provider, announces today the acquisition of booknowmed.com. Read Original Copy
by rss feed | May 14, 2021 | News Feeds
A new study published in the Proceedings of the National Academy of Sciences shows that the vast majority of the viral load in a community at any given point is present in a very small minority of the infected population, underlining the vast differences in viral...
by rss feed | May 14, 2021 | News Feeds
A recent study in the journal JDS Communications reports the results of an analysis of five brands of kefir on the US market, indicating the need for stricter regulation of this field. Read Original...
by rss feed | May 14, 2021 | News Feeds
Earlier, herpes simplex virus (HSV), influenza virus A, measles virus, cytomegalovirus (CMV), and mumps virus have all been associated with after-effects of the virus that includes Parkinson's disease (PD). This list may now include SARS-CoV-2. Read Original...